Stem Cell-Derived Islets Still Producing Insulin at 1 Year

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 diabetes in whom the benefits outweigh the risks of immunosuppression.
Medscape Medical News

source https://www.medscape.com/viewarticle/stem-cell-derived-islets-still-producing-insulin-1-year-2025a1000glb?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost